National Grand Rounds Online Webcast Archive

 

National Grand Rounds – April 2013
View Online Archive, Earn CME*

The AMSA Scorecard: The State of Medical School Conflict-of-Interest Policies and Cultivating a New Era of Effective Change

Tuesday, April 9, 2013 from 12-1pm (EST)

Georgetown University Medical Center, Washington, DC 20057

Speakers:

• Reshma Ramachandran, Pharmfree Fellow, American Medical Student Association
• Daniel Carlat, MD, Director of the Pew Prescription Project

Link to Webcast Archive

_______________ _________________

National Grand Rounds – February 2013
Webcast Archive

Conflict-of-Interest in Medicine:
An Update on the State of the Problem

Featured Speaker:

Howard Brody, MD, PhD
Director, Institute for the Medical Humanities,
Professor, Family Medicine, University of Texas Medical Branch

Click to View

This event was recorded at a live event held on February 8, 2013 in collaboration with

The McGovern Center for Humanities and Ethics
UT Health, University Health Science Center at Houston

Broadcast live from the

University of Texas Medical School

______________________ _________________

National Grand Rounds – November 2012
View Online Archive, Earn CME*

Selling Drugs: Pharma’s Evolving Strategies

This event was held in conjunction with the NPA 7^th Annual Conference Leading the Way: the Next Chapter in America’s Health at the Hilton Alexandria Old Town in Alexandria, VA.

Featured Speakers:

• Shannon Brownlee, MS, Acting Director, Health Policy Program, New America Foundation
• Michael Oldani, PhD, MS, Associate Professor of Medical Anthropology and Director of the Family and Health Studies Program at the University of Wisconsin
• Wells Wilkinson, JD, Project Director, Prescription Access Litigation at Community Catalyst
• Jeff Chester, MSW, Executive Director, Center for Digital Democracy

View Webcast Archive

*This online activity offers
AMA PRA Category 1 Credit™

(Click here for CME Accreditation details)

_____________________________________ ______________

National Grand Rounds – October 2012
View Online Archive, Earn CME*

Managing Industry Conflict of Interest
in the Clinical & Academic Setting

Sponsored by NPA in conjunction with the American Medical Student Association (AMSA)
Empowering Future Physicians Conference, at Nova Southeastern University and College of Osteopathic Medicine, Fort Lauderdale, Florida. Live webcast recorded October 12, 2012.

Featured Speakers:

• Anthony Silvagni, DO, PharmD, MSc, FACOFP, FAFPE, Dean, Nova Southeastern University, School of Osteopathic Medicine
• David Evans, MD, Assistant Professor, Department of Family Medicine, University of Washington School of Medicine
• Gary Wimsett, Jr., JD, LHRM, Director, Conflict of Interest Program, University of Florida College of Medicine

View Webcast Archive

*This online activity offers
AMA PRA Category 1 Credit™

(Click here for CME Accreditation details)

____________________________________________________

National Grand Rounds – May 2012

Understanding Emerging Trends in Industry-Academic Relationships

Sponsored by NPA and the University of Connecticut School of Medicine, Community & Continuing Medical Education and Academic Affairs & Education. Live webcast recorded May 31, 2012.

Featured Speaker:

• Eric G. Campbell, PhD, Associate Professor of Medicine, Harvard Medical School, Director of Research at the Mongan Institute for Health Policy

View Webcast Archive

__________________________________

Want to Learn More?

Visit NPA’s Avoiding Conflict-of-Interest in Medicine Leadership Development Call Series Archive -Link

If you have more questions please contact Ann Woloson, NPA Director of Education at ann.woloson@npalliance.net

________________________________________

These events are offered as part of the Partnership to Advance Conflict-free Medical Education (PACME). This partnership and related materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the
marketing of the prescription drug Neurontin.